pharmaceuticals

With the third wave of the coronavirus taking over the country, the US has seen more than 13,9 million confirmed cases and over 273,000 deaths so far, the New York Times has reported. According to Johns Hopkins data, the test-positivity rates have exceeded a World Health...

The U.S. Food and Drug Administration's approval machinery churned out a lot of disappointments in November. Most of the negative verdicts were tied to difficulties the agency has had in inspecting facilities where investigational drugs are being manufactured, amid COVID-19-related...

Berkshire Hathaway Inc (NYSE: BRK-A) (NYSE: BRK-B) Chairman Warren Buffett has invested in four large drugmakers as the world faces yet another wave of the raging COVID-19 pandemic. What Happened: Regulatory filings made with the United States Securities and Exchange Commission reveal that the...

The pharmaceutical industry has delivered a C$1 billion ($761 million) proposal to the Canadian government in an attempt to stave off an upcoming price crackdown, Reuters reported on Sunday, based on documents the news agency has reviewed. What Happened: The industry offered to...

Pfizer Inc. (NYSE: PFE) has disclosed in its earnings report that it received an official request for information from the US Securities and Exchange Commission, according to The Wall Street Journal. What Happened: The pharmaceutical company received formal requests regarding its...

Biotech stocks continued to sway to the tunes of the broader market in the week ended Oct. 30, which succumbed to geopolitical and macroeconomic concerns. Several big-name pharma companies, including Merck & Co. Inc. (NYSE: MRK) and Pfizer Inc. (NYSE: PFE), reported earnings during the week....

Walmart Inc (NYSE: WMT) has taken preemptive legal action against the federal government to avoid a civil lawsuit against the company related to the operation of its 5,000 in-store pharmacies, the Wall Street Journal reported Thursday. What Happened: The Bentonville, Arkansas-headquartered...

Pfizer Inc (NYSE: PFE) is making a $200 million in Chinese company CStone Pharmaceuticals through a subsidiary, the latter announced Wednesday. What Happened: The New York pharmaceutical company will own a 9.9% stake in CStone as a result of the investment and will gain the rights to...

Regeneron Pharmaceuticals, Inc (NASDAQ: REGN) announced Tuesday that its antibody cocktail drug showed positive effects in non-hospitalized COVID-19 patients. What Happened: Analysis of data from a 275 person study indicates that the REGN-COV2 drug cocktail led to reduced viral load and time...

New York Governor Andrew Cuomo on Thursday announced the state has filed civil charges against Johnson & Johnson (NYSE: JNJ), accusing it of insurance fraud in connection with understating the risks posed by opioid drugs to doctors and elderly patients.  What Happened: The...

An Eastman Kodak Co. (NYSE: KODK) board member and his wife donated nearly half their stock holding in the company, amounting to 3 million shares, to a religious charity on a day when the company’s stock hit its highest valuation since 2014, the Wall Street Journal...

The federal government is halting a $765 million loan to Eastman Kodak Company (NYSE: KODK) for its generic drug-making foray until the company is cleared of insider trading allegations. What Happened "On July 28, we signed a Letter of Interest with Eastman Kodak. Recent allegations of...

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Verdemed, a Canadian pharmaceutical cannabis company, is on a mission to bring cannabinoid-based medicinal products to Latin America. But...

The United States Federal Trade Commission and the New York Attorney General's office are suing Vyera Pharmaceuticals LLC and former CEO Martin Shkreli for anti-competitive practices. What Happened Vyera, formerly known as Turing Pharmaceuticals, led by Shkreli, attempted to stifle...

As technology pours into the logistics industry and illuminates supply chain blind spots, opportunities for efficiency and profit abound.  The pharmaceutical industry, for instance, loses at least $15 billion of product each year to temperature deviations that force cargo disposal. When taking...